Completed

NCT Number: NCT06763978

Comparative Analysis of Isolated Venous, Isolated Arterial, and Standard Access for Transcatheter Closure of Patent Ductus Arteriosus (PDA)

We enrolled all patients with a hemodynamically significant PDA demonstrated by patient clinical condition, and by PDA size & left chamber dilatation on echocardiography attending at Cardiology Department to we compare the use of a single venous access and a single arterial access with the standard approach requiring both venous and arterial access for transcatheter PDA closure regarding the outcome & complications.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemodynamically Significant PDA

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tanta University

Tanta, 82005, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

any patient with hemodynamically significant PDA

Exclusion criteria

patient with pulmonary hypertension and Eisenmenger syndrome

Treatment and study plan

Transcatheter PDA Closure

Device

Transcatheter PDA closure

Primary outcomes

procedural and fluoroscopy time

Time frame: during the procedure

Sponsors and collaborators

Lead sponsor

Egyptian Biomedical Research Network

Network

Registry information

Important dates

Study start: 2020
Primary completion: 2024
Study completion: 2024
First posted: Jan 8, 2025
Registry last updated: Jan 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.